Comments
Indian cough syrup manufacturer Maiden Pharmaceuticals is trying to find out from its buyer in Gambia details related to the deaths of children which the World Health Organization said may have been linked to its products, one of its directors said on Thursday.
"We are trying to find out the situation because it cropped up only today morning," Naresh Kumar Goyal told Reuters. "We are trying to find out with the buyer and all that what has happened exactly. We are not selling anything in India."
WHO Director-General Tedros Adhanom Ghebreyesus on Wednesday told reporters the UN agency was investigating 66 deaths from acute kidney injuries with India's drug regulator.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.